Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions

Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions

Abstract The 2019 coronavirus disease (COVID‐19) pandemic has become a global crisis. In the immunopathogenesis of COVID‐19, SARS‐CoV‐2 infection induces an excessive inflammatory response in patients, causing an inflammatory cytokine storm in severe cases. Cytokine storm leads to acute respiratory...

Full description

Bibliographic Details
Main Authors:	Yujie Jiang, Tingmei Zhao, Xueyan Zhou, Yu Xiang, Pedro Gutierrez‐Castrellon, Xuelei Ma
Format:	Article
Language:	English
Published:	Wiley 2022-09-01
Series:	MedComm
Subjects:	COVID‐19 cytokine storm immunopathology immunotherapy inflammatory pathways
Online Access:	https://doi.org/10.1002/mco2.154

Similar Items

Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
by: Ali A. Rabaan, et al.
Published: (2021-04-01)

Human Coronaviruses: Counteracting the Damage by Storm
by: Dewald Schoeman, et al.
Published: (2021-07-01)

Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
by: Ligong Lu, et al.
Published: (2020-07-01)

Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
by: Mattia Emanuela Ligotti, et al.
Published: (2021-09-01)

Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19
by: Zhen Qin, et al.
Published: (2021-02-01)

Determining the disease outcome by cytokine storm during infectious diseases and targeting cytokines during Sepsis: Possible therapeutic options
by: Tasbir Amin, et al.
Published: (2022-12-01)

Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: A consequence of an immune reconstitution inflammatory syndrome?
by: Emeline Vinatier, et al.
Published: (2022-08-01)

Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19
by: Anna Paola Capra, et al.
Published: (2023-09-01)

Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations
by: Abdusalam Abdullah Alarabei, et al.
Published: (2024-03-01)

Immunopathology of American cutaneous leishmaniasis
by: Claude Pirmez
Published: (1992-01-01)

Meeting the Challenge of Controlling Viral Immunopathology
by: Engin Berber, et al.
Published: (2024-04-01)

IMMUNOPATHOLOGY OF ALLERGIC CONJUNCTIVITIS
by: DeGaulle I. Chigbu, et al.
Published: (2020-10-01)

Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus
by: Timothy Andrew Gottschalk, et al.
Published: (2015-10-01)

The potential for traditional Chinese therapy in treating sleep disorders caused by COVID-19 through the cholinergic anti-inflammatory pathway
by: Xiaoxia Xie, et al.
Published: (2022-10-01)

Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19
by: Gábor Kökény, et al.
Published: (2023-01-01)

Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis
by: Syed Faizan Mehdi, et al.
Published: (2022-04-01)

Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
by: Basil Mohammed Alomair, et al.
Published: (2023-04-01)

THE ROLE OF CYTOKINES IN THE IMMUNITY DEVELOPMENT AT HELMINTHIASIS
by: E. A. Grishina
Published: (2016-12-01)

Immunological and Clinical Aspects of Immune Responses to SARS-CoV-2
by: Ali Reza Andalib, et al.
Published: (2021-03-01)

The Role of Cytokines and Chemokines in Filovirus Infection
by: Sandra L. Bixler, et al.
Published: (2015-10-01)

In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review
by: Yenddy N. Carrero, et al.
Published: (2021-05-01)

Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease
by: Jorge Rodrigues de Sousa, et al.
Published: (2017-11-01)

Changes in the immune status of HIV-infected individuals with chronic toxoplasmosis infestation and toxoplasmosis encephalitis
by: I.H. Hryzhak
Published: (2017-02-01)

Controlling viral inflammatory lesions by rebalancing immune response patterns
by: Sachin Mulik, et al.
Published: (2023-08-01)

Novel therapeutic role of Ganoderma Polysaccharides in a septic mouse model - The key role of macrophages
by: Wei Xiong, et al.
Published: (2024-03-01)

Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection
by: Victor H. Leyva-Grado, et al.
Published: (2017-05-01)

RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond
by: Xiaoyu Liu, et al.
Published: (2023-04-01)

New insights into the immunopathology of early Toxocara canis infection in mice
by: Nathália M. Resende, et al.
Published: (2015-07-01)

Corrigendum: RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond
by: Xiaoyu Liu, et al.
Published: (2023-11-01)

A 21st Century Evil: Immunopathology and New Therapies of COVID-19
by: Taylon Felipe Silva, et al.
Published: (2020-10-01)

EXPRESSION DENSITY OF RECEPTORS FOR IMMUNOREGULATORY MEDIATORS AS A MODULATORY COMPONENT OF BIOLOGICAL EFFECTS OF MEDIATORS UPON CELLS (PART 2)
by: S. V. Sennikov, et al.
Published: (2019-07-01)

EXPRESSION DENSITY OF RECEPTORS TO IMMUNOREGULATORY MEDIATORS AS A MODULATING COMPONENT OF BIOLOGICAL EFFECTS OF MEDIATORS ON CELL. PART 1
by: S. V. Sennikov, et al.
Published: (2019-05-01)

Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
by: Vincenzo Lariccia, et al.
Published: (2020-12-01)

IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+Foxp3+ regulatory T lymphocytes
by: Cécile Apert, et al.
Published: (2022-09-01)

Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus—and Cytokine-Mediated Damage of Heart Tissue During Myocarditis
by: Antje Beling, et al.
Published: (2018-11-01)

Cytokine Profiling among Children with Multisystem Inflammatory Syndrome versus Simple COVID-19 Infection: A Study from Northwest Saudi Arabia
by: Hany M. Abo-Haded, et al.
Published: (2022-06-01)

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
by: Zhiyu Wang, et al.
Published: (2020-07-01)

Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch
by: Yuejia Lan, et al.
Published: (2022-09-01)

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors
by: Noelia Vilariño, et al.
Published: (2020-08-01)

Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
by: Sonu Bhaskar, et al.
Published: (2020-07-01)